Nephrology
NPI
1962468397
Specialty
Nephrology
Group practices
0
Medicare group memberships
Hospitals
4
Hospital affiliations
Medicare paid, 2024
$323K
4,861 services
Medicare patients, 2024
807
Average age 76
Drug cost, 2024
$2.6M
18,680 prescriptions
Company payments, 2025
$81.63
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Terry Overby was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,464 times for 594 patients. In total Terry Overby billed 4,861 services in 35 codes, and Medicare paid $323K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: -.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,464 | 594 | $11.59 | $17K |
| 99214 Office E&M - Established | Office | 1,003 | 494 | $88.92 | $89K |
| 99213 Office E&M - Established | Office | 784 | 479 | $61.59 | $48K |
| 90961 ESRD Related Services (not dialysis) | Office | 222 | 75 | $225.80 | $50K |
| 99232 Hospital E&M - Subsequent | Facility | 186 | 73 | $60.56 | $11K |
| 90960 ESRD Related Services (not dialysis) | Office | 163 | 73 | $273.32 | $45K |
| G0008 Administration of influenza virus vaccine | Office | 117 | 112 | $26.60 | $3,112 |
| 90653 Vaccine Product | Office | 98 | 98 | $81.82 | $8,018 |
| 90935 Hemodialysis | Facility | 89 | 33 | $54.48 | $4,849 |
| 99233 Hospital E&M - Subsequent | Facility | 79 | 65 | $91.20 | $7,205 |
| 99222 Hospital E&M - Initial | Facility | 67 | 57 | $99.12 | $6,641 |
| 90966 ESRD Related Services (not dialysis) | Office | 50 | 13 | $226.12 | $11K |
| 99215 Office E&M - Established | Office | 30 | 28 | $125.80 | $3,774 |
| 99223 Hospital E&M - Initial | Facility | 27 | 26 | $133.28 | $3,599 |
| 99204 Office E&M - New | Office | 20 | 20 | $129.89 | $2,598 |
By year: 2022 $419K for 4,449 services; 2023 $376K for 3,880 services; 2024 $323K for 4,861 services.
Medicare prescription drug claims, 2024
In 2024, the drug Terry Overby prescribed most often to Medicare patients was Levothyroxine Sodium, with 807 prescriptions and refills. In total Terry Overby wrote 18,680 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 807 | 1,910 | 167 | $6,694 |
| Atorvastatin Calcium Generic | 715 | 1,839 | 173 | $6,412 |
| Furosemide Generic | 686 | 1,604 | 174 | $3,682 |
| Metoprolol Succinate Generic | 658 | 1,652 | 162 | $9,290 |
| Nifedipine Er Nifedipine | 579 | 1,249 | 122 | $16K |
| Losartan Potassium Generic | 546 | 1,350 | 137 | $4,987 |
| Pantoprazole Sodium Generic | 499 | 1,268 | 132 | $7,136 |
| Indapamide Generic | 426 | 952 | 101 | $4,897 |
| Eliquis Apixaban | 407 | 642 | 71 | $369K |
| Carvedilol Generic | 374 | 833 | 84 | $2,404 |
| Allopurinol Generic | 298 | 709 | 72 | $2,572 |
| Gabapentin Generic | 284 | 540 | 70 | $4,878 |
| Pravastatin Sodium Generic | 276 | 702 | 68 | $3,309 |
| Potassium Chloride Generic | 270 | 628 | 67 | $8,780 |
| Omeprazole Generic | 247 | 607 | 57 | $2,324 |
Brand drugs: 3,066 claims; generic drugs: 15,315 claims; opioid claims: 500.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Terry Overby $81.63 ($81.63 in general payments such as food, travel and fees) from 4 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $31.39.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.